Amylyx Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Amylyx Pharmaceuticals, Inc.

Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR…

Biotechnology
US, Cambridge [HQ]
Competitors · Subsidiaries · Locations

Business Intelligence

U.S. · Business Intelligence
Worldwide · Business Intelligence
Worldwide · Subsidiaries Table
Subsidiary Private? Country City
- - - -
End of AMLX's Analysis
CIK: 1658551 CUSIP: 03237H101 ISIN: US03237H1014 LEI: - UEI: -
Secondary Listings
AMLX has no secondary listings inside our databases.